AstraZeneca
Oct 15, 2026

AstraZeneca teams up with insitro on AI drug discovery deal worth up to $1.86 billion

AstraZeneca has entered an AI drug discovery partnership with biotech company insitro, in a deal valued at up to $1.86 billion. Techub, citing Crypto Briefing, reported that the agreement is aimed at using artificial intelligence to speed up the drug discovery process. The partnership brings together a major pharmaceutical company and an AI-focused biotech firm at a time when the use of machine learning in life sciences continues to draw attention. The report also said the collaboration could reshape industry dynamics, though no additional terms were disclosed in the source summary. The announcement centers on the size of the deal, the companies involved, and the role AI is expected to play in accelerating early-stage drug development.

760
AstraZeneca teams up with insitro on AI drug discovery deal worth up to $1.86 billion